Breaking News

Relay Therapeutics Inc (RLAY)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

5.96 -0.15 -2.46%

16:00:00 - Closed. Currency in USD ( Disclaimer )

After Hours

6.02

+0.06

+1.00%

16:25:10 - Real-time Data

Type: Equity

Market: United States

Volume: 2,327,639
Bid/Ask: 5.96 / 6.02
Day's Range: 5.93 - 6.34

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
Financials
Technical
Forum

RLAY Income Statement

Featured here, the Income Statement (earnings report) for Relay Therapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Annual Quarterly

Advanced Income Statement

Collapse All

Period Ending:

2023

31/12

2023

30/09

2023

30/06

2023

31/03

Total Revenue

-0.001

25.2

0.119

0.226

Revenue	-0.001	25.2	0.119	0.226
Other Revenue, Total	-	-	-	-

Cost of Revenue, Total

73.86

81.49

88.2

82.83

Gross Profit

-73.87

-56.29

-88.08

-82.6

Total Operating Expenses

94.26

99.98

108.32

102.41

Selling/General/Admin. Expenses, Total	20.4	18.48	20.12	19.58
Research & Development	77.5	81.49	88.2	82.83
Depreciation / Amortization	-3.89	1.36	1.33	1.2
Interest Expense (Income) - Net Operating	-	-	-	-
Unusual Expense (Income)	-	-	-	-
Other Operating Expenses, Total	-73.6	-82.86	-89.54	-84.02

Operating Income

-94.26

-74.78

-108.2

-102.18

Interest Income (Expense), Net Non-Operating

Gain (Loss) on Sale of Assets

Other, Net

-10.77

-9.04

-9.7

-7.94

Net Income Before Taxes

-83.5

-65.73

-98.5

-94.24

Provision for Income Taxes

Net Income After Taxes

-83.5

-65.73

-98.5

-94.24

Minority Interest

Equity In Affiliates

U.S GAAP Adjustment

Net Income Before Extraordinary Items

-83.5

-65.73

-98.5

-94.24

Total Extraordinary Items

Net Income

-83.5

-65.73

-98.5

-94.24

Total Adjustments to Net Income

Income Available to Common Excluding Extraordinary Items

-83.5

-65.73

-98.5

-94.24

Dilution Adjustment

Diluted Net Income

-83.5

-65.73

-98.5

-94.24

Diluted Weighted Average Shares

124.75

122.23

121.68

121.32

Diluted EPS Excluding Extraordinary Items

-0.669

-0.538

-0.81

-0.777

DPS - Common Stock Primary Issue

Diluted Normalized EPS

-0.429

-0.342

-0.517

-0.491

* In Millions of USD (except for per share items)

Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

RLAY Comments

Write your thoughts about Relay Therapeutics Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Natty Dred Apr 19, 2023 10:18AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Their S-1 states they're collaborating with D. E. Shaw Research, to gain better understanding of the 3D dynamic nature of their protein targets, to find alosteric binding sites that may be more specific in action and results in fewer adverse events.This particular drug targets a well known prtein that has failed all previous attempts because of AE The success demonstrated yesterday validates this approach.The stock has 20% short interest with 10 days to cover and is almost entirely institution owned. I suspect either a large institution is being forced to sell for unrelated reasons, or a large short has realized their mistake and is manipulating the price, by triggering asell circuit breaker, in order to cover.

0 0

Report

Miroslav Petkov Jul 24, 2020 11:36AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

someone have more info for this company ?

0 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="214889222">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="214889222" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="214889222" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="214889222">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	37,973.0	+197.6	+0.52%
US 500	4,965.5	-45.6	-0.91%
Dow Jones	37,986.40	+211.02	+0.56%
S&P 500	4,967.23	-43.89	-0.88%
Nasdaq	15,282.01	-319.49	-2.05%
S&P 500 VIX	18.71	+0.71	+3.94%
Dollar Index	105.960	-0.022	-0.02%

Crude Oil WTI	83.25	+0.52	+0.63%
Brent Oil	87.38	+0.27	+0.31%
Natural Gas	1.760	+0.003	+0.17%
Gold	2,406.75	+8.75	+0.36%
Silver	28.747	+0.367	+1.29%
Copper	4.4930	+0.0565	+1.27%
US Soybeans	1,150.50	+15.50	+1.37%

U.S. 10Y	4.623	-0.026	-0.56%
U.S. 30Y	4.713	0.002	0.04%
U.S. 5Y	4.672	0.016	0.34%
U.S. 3M	5.411	+0.014	+0.27%
US 10Y T-Note	107.84	+0.14	+0.13%
Euro Bund	131.04	-0.17	-0.13%
10-2 Yield Spread	-35.57	-0.87	2.51%

Apple	165.00	-2.04	-1.22%
Alphabet A	154.09	-1.92	-1.23%
Tesla	147.05	-2.88	-1.92%
Amazon.com	174.63	-4.59	-2.56%
Netflix	555.04	-55.52	-9.09%
Meta Platforms	481.07	-20.73	-4.13%
Bank of America	36.97	+1.20	+3.35%

Recent Quotes

	Name	Price	Chg.	Chg. %
	RLAY	5.96	-0.15	-2.46%

Market Movers

Name	Last	Chg. %	Vol.
TSLA	147.05	-1.92%	85.13M
NVDA	762.00	-10.00%	83.24M
AMD	146.64	-5.44%	69.79M
AMZN	174.63	-2.56%	52.17M
MSFT	399.12	-1.27%	27.50M
META	481.07	-4.13%	24.64M
SMCI	713.65	-23.14%	17.01M

Name	Last	Chg. %	Vol.
PARA	12.44	+13.40%	42.98M
AXP	231.05	+6.23%	6.88M
FITB	36.25	+5.93%	13.58M
WBA	18.24	+3.70%	10.48M
KMI	18.84	+3.46%	25.44M
BAC	36.97	+3.35%	50.41M
CFG	34.00	+3.34%	6.51M

Name	Last	Chg. %	Vol.
SMCI	713.65	-23.14%	17.01M
NVDA	762.00	-10.00%	83.24M
NFLX	555.04	-9.09%	16.27M
JBL	118.75	-8.36%	2.91M
AMD	146.64	-5.44%	69.79M
MRVL	62.13	-4.77%	12.32M
MPWR	591.52	-4.64%	656.26K